AstraZeneca PLC
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AstraZeneca PLC's yearly results (2022–2025), compared with companies in United Kingdom. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 91% of companies in United Kingdom.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$158Over the last 3 years, every $100 of reported profit came with $158 of operating cash.
Lower than 54% of companies in United Kingdom.
Self-Funding Ratio
2.6×Over the last 3 years its own operating cash covered its investment spending (capex) 2.6 times.
Lower than 56% of companies in United Kingdom.
Cash Locked Ratio
$16For every $100 of sales, $16 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $14 tied up three years earlier.
More money tied up than 67% of companies in United Kingdom.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 91% of companies in United Kingdom.
Growth Efficiency Ratio
$48Sales grew 32% in 3 years; of every extra $100 of sales, $48 became extra profit.
Higher than 81% of companies in United Kingdom.
Asset Productivity Ratio
+32% / +18%In 3 years sales changed by +32% while total assets changed by +18%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
5.5×Debt due within a year is covered 5.5 times by its yearly operating cash.
Higher than 53% of companies in United Kingdom.
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
48%Of every $100 the company owns, $48 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 83% of companies in United Kingdom.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 72% of companies in United Kingdom.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
AstraZeneca PLC owes $0.57 for every $1 it owns. Net profit rose 45% in the year to Dec 2025, and grew 46% a year on average over 3 years.
Compared with companies in United Kingdom · latest annual results Dec 2025.
P/E ratio
26.0Investors pay $26.0 for every $1 of AstraZeneca PLC's yearly profit, higher than 65% of companies in United Kingdom.
P/B ratio
5.36The share price is 5.36 times AstraZeneca PLC's book value per share, higher than 75% of companies in United Kingdom.
Market cap
£201.3 BThe total market value of all of AstraZeneca PLC's shares at today's price (share price × number of shares), larger than 97% of companies in United Kingdom. PosiCap size class: Tito Cap.
Net worth (book value)
$50.3 BWhat AstraZeneca PLC would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Return on equity (ROE)
22.0%AstraZeneca PLC earned 22.0% on its shareholders' money over the last year, higher than 73% of companies in United Kingdom.
Owes vs Owns
0.57×AstraZeneca PLC owes $0.57 for every $1 it owns (moderate), lower than 60% of companies in United Kingdom.
Dividend yield
1.89%AstraZeneca PLC pays 1.89% of its share price as dividends a year, lower than 68% of dividend-paying companies in United Kingdom.
Revenue growth
+9%Revenue rose 9% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
+45%Net profit rose 45% in the year to Dec 2025, and grew 46% a year on average over 3 years.
Profit margin
17.4%AstraZeneca PLC keeps $17 of every $100 of revenue as net profit.
Cash quality
1.4×Cash from AstraZeneca PLC's business was 1.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
8.3×AstraZeneca PLC's operating profit covered its interest costs 8.3 times in the year to Dec 2025.
Cash vs debt
Net debtAstraZeneca PLC had $23.4 B more debt than cash (net debt) at Dec 2025.
Questions
What is AstraZeneca PLC's P/E ratio?
Investors pay $26.0 for every $1 of AstraZeneca PLC's yearly profit, higher than 65% of companies in United Kingdom.
What is AstraZeneca PLC's return on equity?
AstraZeneca PLC earned 22.0% on its shareholders' money over the last year, higher than 73% of companies in United Kingdom.
How much does AstraZeneca PLC owe compared with what it owns?
AstraZeneca PLC owes $0.57 for every $1 it owns (moderate), lower than 60% of companies in United Kingdom.
Does AstraZeneca PLC pay a dividend?
Yes. AstraZeneca PLC pays 1.89% of its share price as dividends a year, lower than 68% of dividend-paying companies in United Kingdom.
Is AstraZeneca PLC's revenue growing?
Revenue rose 9% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.